What IFA Celtics does

IFA Celtics, legally Investigación Farmacéutica S.A. de C.V., is a privately held Mexican pharmaceutical manufacturer founded in 1965. The company operates across four therapeutic divisions — Salud Metabólica (metabolic health, focused on obesity and overweight since 1987), Salud Femenina (women's health across life stages), Salud Mental (neuropsychiatric disorders), and NutraCeltics (nutritional supplements and herbal medicines) — plus the Sexualidad Informada sub-brand built around its pioneering emergency contraception franchise (Postday, launched 2004). The company owns and operates manufacturing facilities at the CIVAC industrial park in Jiutepec, Morelos, producing solid oral dosage forms (tablets, prolonged-release tablets, hard gelatin and prolonged-release capsules, dragees, and powders) for pharmaceutical, hormonal, and dietary supplement lines under NOM-059-SSA1-2015, current GMP, ISO 9001, and PROFEPA Clean Industry certifications, with an active SSA sanitary license (No. 173300201B0224).

The business model is B2B and institutionally channeled: products reach patients via prescriptions from healthcare professionals (engaged through a gated medical portal at ifaonline.com.mx, toll-free customer service lines, and continuous medical education programs running since 1990) and via supply into the Mexican public healthcare system. Revenue is generated through one-time sales of branded and generic medications; pricing is not publicly disclosed and is consistent with B2B/institutional contracting rather than direct-to-consumer retail. The customer base consists of prescribing physicians and the public healthcare sector in Mexico, with no disclosed export operations or international distribution.

On the technology side, the company's most recent strategic move is an October 2025 partnership with ForgeStop Technology Corp to deploy NFC-enabled smart packaging — making IFA Celtics the first Mexican pharmaceutical company to implement smartphone-based anti-counterfeit verification, addressing supply-chain integrity for pharmaceutical distribution. Beyond manufacturing certifications and the new NFC layer, no AI/ML, data platform, or software-as-a-service components are part of the current offering. Ownership is privately held with no disclosed parent company, subsidiaries, or external funding rounds.

Name

IFA Celtics

Legal name

Investigación Farmacéutica, S.A. de C.V.

Website

https://ifaonline.com.mx

Company type

Private

Founded year

1965

Operating status

Operating

Headcount range

251–500 employees

Short description

IFA Celtics is a privately held Mexican pharmaceutical manufacturer founded in 1965, producing branded and generic medications across metabolic health, women's health, mental health, and nutritional supplements for the Mexican healthcare system through professional and institutional channels.

Ownership category

akta.pro rank

Product category

Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Weight Management & Metabolic Supplements (CRADAGAG)

akta.pro secondary industries

Medical Nutrition & Meal Replacement (RTD, Bars, Powders) (CRADAGAN), Healthy Aging & Cognitive Support Supplements (CRADAGAM)

Keywords

• Generic pharmaceuticals
• Women's health medications
• Obesity treatment drugs
• Nutritional supplements
• Pharmaceutical manufacturing

Headquarters

HQ city

Alvaro Obregón

HQ country

Mexico

HQ region

Latin America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Marketing or Sales, Technology or R&D, Supply Chain, Infrastructure

Revenue model

1. Pharmaceutical Products: Sale of branded and generic pharmaceutical medications across multiple therapeutic divisions including metabolic health (obesity/overweight), women's health, mental health, and nutritional supplements.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

IFA Celtics is a Mexican pharmaceutical company that manufactures and distributes branded and generic medications across four therapeutic divisions: Metabolic Health (obesity/overweight), Mental Health (neuropsychiatric disorders), Women's Health (including emergency contraception), and NutraCeltics (nutritional supplements and herbal medicines). The company operates its own manufacturing plant in Jiutepec, Morelos, producing solid oral dosage forms (tablets, capsules, dragees, powders) and distributes products through healthcare professionals and the Mexican healthcare system.

Product overview

IFA Celtics is a Mexican pharmaceutical company with over 50 years of experience, operating as a pharmaceutical manufacturer and developer. The company offers a multi-divisional portfolio organized into four therapeutic areas: Metabolic Health (Salud Metabólica) focused on obesity and overweight treatment; Mental Health (Salud Mental) for neuropsychiatric disorders; Women's Health (Salud Femenina) covering all life stages; and NutraCeltics for dietary supplements and herbal medications. The company also runs Sexualidad Informada, a pioneer emergency contraception program in Mexico. IFA Celtics provides manufacturing services for pharmaceutical products, hormonal products, and dietary supplements, producing various solid oral dosage forms (tablets, capsules, dragees, powders) at their world-class manufacturing plant in Jiutepec, Morelos.

Differentiator

Problem solved

Functional benefit

Brands

• Salud Metabólica: Metabolic health division focused on obesity and overweight treatment with versatile, safe, and effective product portfolio.
• Salud Mental
• Salud Femenina
• NutraCeltics
• Sexualidad Informada

Products and services

• Salud Metabólica (Metabolic Health Division) Division focused on obesity and overweight treatment with versatile, safe, and effective product portfolio. Targeted at healthcare professionals treating metabolic disorders in Mexico.
• Salud Mental (Mental Health Division)
• Salud Femenina (Women's Health Division) Division providing comprehensive medication portfolio for each stage of women's life with scientific backing for well-being, safety, and quality of life. Targeted at gynecologists and women's health specialists.
• NutraCeltics (Dietary Supplements & Herbal Medicines) Division of dietary supplements and herbal medications focused on maintaining a healthy lifestyle. Targeted at healthcare professionals recommending nutritional supplements.
• Sexualidad Informada (Informed Sexuality / Emergency Contraception Program) Pioneer emergency contraception program in Mexico, including Postday and Movuren products. Targeted at healthcare professionals prescribing emergency contraception.
• Postday (Emergency Contraception) Emergency contraception pill, with IFA being a pioneer in this category in Mexico since 2004. Prescribed by healthcare professionals.
• Movuren (Emergency Contraception) Emergency contraception product launched in 2016 as part of the Sexualidad Informada program.
• Klodex Solution Mental health product launched in 2019 in the Mental Health line for treatment of neuropsychiatric disorders.
• Pharmaceutical Products Manufacturing Contract manufacturing of pharmaceutical products in modern world-class facilities with Good Manufacturing Practices certification. Includes production of solid oral dosage forms: tablets, prolonged-release tablets, compressed tablets, hard gelatin capsules, prolonged-release capsules, dragees, and powders.

Named customers2 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• ForgeStop Technology CorpcoreTechnology or Integration · 22 October 2025IFA Celtics partnered with ForgeStop Technology Corp to deploy NFC-enabled smart packaging technology, becoming Mexico's first pharmaceutical company to implement this anti-counterfeit solution. The technology enables real-time verification of medicines using smartphones, aiming to combat counterfeit drugs and improve supply chain transparency throughout the pharmaceutical distribution network.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Laboratorios Pisa: One of Mexico's largest pharmaceutical manufacturers with a broad portfolio of generics, branded generics, and hospital products across multiple therapeutic areas. Directly comparable as a Mexican-based pharma manufacturer targeting the same healthcare system and physician channel.
• Laboratorios Liomont: Mexican pharmaceutical manufacturer with strong presence in women's health, metabolic, and OTC categories. Closely comparable to IFA in therapeutic area mix, Mexican market focus, and physician-led GTM motion.
• Laboratorios Silanes: Established Mexican pharmaceutical company with branded generics and innovative products across metabolic, cardiovascular, and women's health. Comparable as a long-standing domestic pharma peer competing for the same physician prescriptions and institutional contracts.
• Genomma Lab Internacional: Mexican pharmaceutical company focused on OTC and personal care products with strong consumer brand portfolio. Comparable in domestic Mexican market presence and therapeutic breadth, though with a more consumer/OTC orientation than IFA's prescription focus.
• Probiomed: Mexican biotech and pharmaceutical manufacturer with focus on biosimilars, generics, and specialty therapeutics. Comparable as a Mexican manufacturer competing in similar therapeutic categories with in-house manufacturing capabilities.

Regional players

• Grupo Farmacéutico Somar: Mexican pharmaceutical group with portfolio across generics and OTC, serving similar healthcare professional channels. Comparable therapeutic categories and distribution through the Mexican healthcare system.
• Landsteiner Scientific: Latin American pharmaceutical company with presence in Mexico focused on specialty and generic medications. Comparable in therapeutic breadth and regional Latin American market exposure, though primarily operating across multiple Latin American geographies.

Broad incumbents

• Apotex: Large Canadian-based global generic pharmaceutical manufacturer with significant presence in Mexico. Comparable in generic drug manufacturing focus, though at much greater scale and with broader international footprint.
• Teva Pharmaceutical Industries: Global generic pharmaceutical leader with operations across Latin America including Mexico. Comparable as a major generic manufacturer competing in the same therapeutic categories, but at vastly greater scale and with broader product portfolio.
• Sandoz (Novartis): Global leader in generic pharmaceuticals and biosimilars with established presence in the Mexican market. Comparable generic manufacturing model and therapeutic breadth, though operating as a global incumbent rather than a domestic specialist.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCGjlVMb8CyE8iEzdhBGpbdQ
• Facebookfacebook.com/tratarlaobesidadseriamente

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IFA Celtics